Perelel to ‘reimagine women’s health’ with $27 million growth investment

By Lollie Hancock | Published: 24-Nov-2025

The targeted nutrition brand will use the $27m investment from Prelude Growth Partners to support Perelel’s journey from prenatal care to a comprehensive women’s health

Doctor-led supplement brand Perelel has secured US$27m in investment from Prelude Growth Partners.

The investment will be used to drive the brand’s mission to provide clinically-proven products that support women through every step of their hormonal life cycle.

Perelel Co-Founders Victoria Thain Gioia, Alex Taylor and Dr. Banafsheh Bayati will use the funding opportunity to ‘reimagine women’s health’.

This new partnership replaces early angel investors with a partner it believes can support the brand through its new stage of growth following a profitable first five years of operation.

Existing investors Unilever Ventures, Willow Growth Partners and Selva Ventures have participated.

“This moment validates what we have built over the past five years: a business that proves women trust and return to brands that invest in clinical rigour and medically backed solutions,” said Gioia, co-founder and CEO of Perelel. 

“As a women-founded firm with deep expertise in scaling consumer health and wellness brands, Prelude Growth understands both our market and our mission. 

“Their proven ability to build category leaders makes them the ideal partner as we evolve beyond pregnancy and postpartum support into a comprehensive women’s health company.

“We’re so excited to add them to our bench of incredible female board members.”

“The women’s health category is at a breaking point with influencer-led brands and unproven product claims,” said Alex Taylor, co-founder of Perelel. 

“As a doctor-founded brand with a commitment to products backed by clinical rigour and robust research, we have built our reputation on a foundation of trust.”

Neda Daneshzadeh, co-founder and Managing Partner of Prelude Growth, added: “Perelel’s doctor-founding, coupled with its clinical validation and commitment to women’s health research, stands out in the category.”

The consumer-focused growth equity firm is no stranger to beauty and wellness, with previous investments into OneSkin, Sol de Jeniro, Summer Fridays and Tower28.

“We are extremely proud to partner with the [Perelel] team to support them in creating a powerhouse brand that is reimagining the future of women’s health,” said Daneshzadeh.

Related content:

You may also like